Centrum Medyczne Pratia Warszawa
About Centrum Medyczne Pratia Warszawa
"Pratia Warszawa to doświadczony ośrodek badań klinicznych. Pratia powstała w trosce o pacjentów, którzy zmagają się z chorobami przewlekłymi i chcą uzyskać dostęp do nowoczesnych metod leczenia, które są w fazie badań klinicznych. Prowadzimy badania w ponad 20 obszarach terapeutycznych między innymi w dermatologi, diabetologi, gastroenterologi, ginekologi, laryngologi, immunologi, kardiologi, neurologi, nefrologi, onkologi, ortopedia pediatrii, pulmonologi, reumatologi, a także badania dotyczące szczepionek. Badania kliniczne proponowane naszym pacjentom uzyskały zgodę Ministerstwa Zdrowia oraz mają pozytywną opinię niezależnej Komisji Bioetycznej."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Shire
4
Amgen
2
Hoffmann-La Roche
2
Intec Pharma Ltd.
2
Janssen Research & Development, LLC
2
Jazz Pharmaceuticals
2
Revance Therapeutics, Inc.
2
Aziende Chimiche Riunite Angelini Francesco S.p.A
1
Ironwood Pharmaceuticals, Inc.
1
MedDay Pharmaceuticals SA
1
Otsuka Pharmaceutical Development & Commercialization, Inc.
1
Clinical Trials at Centrum Medyczne Pratia Warszawa
During the past decade, Centrum Medyczne Pratia Warszawa conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 10 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
2014-03-14
2020-07-22
Completed
4,372
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
2016-09-30
2018-07-23
Completed
6,790
A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients
2016-03-01
2019-12-01
Unknown status
420
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
2016-07-01
2019-12-01
Unknown status
460
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)
2016-12-01
2020-04-23
Terminated
642
A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
2017-07-19
2019-02-25
Terminated
242
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-02-09
2020-10-23
Terminated
380
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
2018-02-27
2023-12-31
Active, not recruiting
557
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centrum Medyczne Pratia Warszawa" #1 sponsor was "Shire" with 4 trials, followed by "Amgen" with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Intec Pharma Ltd." with 2 trials sponsored and "Janssen Research & Development, LLC"
with 2 trials sponsored. Other sponsors include 9 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Pratia Warszawa"
#1 collaborator was "Syneos Health" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "TFS Trial Form Support" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Centrum Medyczne Pratia Warszawa
According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Pratia Warszawa" are
"Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Alzheimer Disease" (2 trials), "Cervical Dystonia" (2 trials) and "Parkinson's Disease" (2 trials). Many other conditions were trialed in "Centrum Medyczne Pratia Warszawa" in a lesser frequency.
Clinical Trials Intervention Types at Centrum Medyczne Pratia Warszawa
Most popular intervention types in "Centrum Medyczne Pratia Warszawa" are "Drug" (21 trials), "Biological" (5 trials) and "Other" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "Ontamalimab" (3 trials), "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "Gantenerumab" (2 trials) and "Nabiximols" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centrum Medyczne Pratia Warszawa
The vast majority of trials in "Centrum Medyczne Pratia Warszawa" are
26 trials for "All" genders.
Clinical Trials Status at Centrum Medyczne Pratia Warszawa
Currently, there are NaN active trials in "Centrum Medyczne Pratia Warszawa".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 9 completed trials in Centrum Medyczne Pratia Warszawa,
undefined suspended trials,
and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Medyczne Pratia Warszawa, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 1 trials that are defined as “Not Applicable".